TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RHHVF Stock 12 Month Forecast
Average Price Target
$411.68
▼(-6.26% Downside)
Based on 11 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is $411.68 with a high forecast of $500.42 and a low forecast of $287.74. The average price target represents a -6.26% change from the last price of $439.16.
Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (NYSE: HCA), Vertex Pharmaceuticals (NASDAQ: VRTX) and Roche Holding AG (Other OTC: RHHVF)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Disc Medicine (NASDAQ: IRON), Nuvalent (NASDAQ: NUVL) and Roche Holding AG (Other OTC: RHHVF)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (NASDAQ: APGE), Regeneron (NASDAQ: REGN) and Roche Holding AG (Other OTC: RHHVF)
BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.
Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (NYSE: HCA), Vertex Pharmaceuticals (NASDAQ: VRTX) and Roche Holding AG (Other OTC: RHHVF)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Disc Medicine (NASDAQ: IRON), Nuvalent (NASDAQ: NUVL) and Roche Holding AG (Other OTC: RHHVF)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (NASDAQ: APGE), Regeneron (NASDAQ: REGN) and Roche Holding AG (Other OTC: RHHVF)
BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 3 Months would result in 87.50% of your transactions generating a profit, with an average return of +9.20% per trade.
Copying Matthew Weston's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +26.25% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +43.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RHHVF Analyst Recommendation Trends
Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
15
15
16
13
10
Hold
9
9
10
13
15
Sell
16
16
20
17
8
Strong Sell
0
0
0
0
0
total
40
40
46
43
33
In the current month, RHHVF has received 10Buy Ratings, 15Hold Ratings, and 8Sell Ratings. RHHVF average Analyst price target in the past 3 months is 411.68.
Each month's total comprises the sum of three months' worth of ratings.
RHHVF Financial Forecast
RHHVF Earnings Forecast
Next quarter’s earnings estimate for RHHVF is $10.83 with a range of $10.83 to $10.83. The previous quarter’s EPS was $13.85. RHHVF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year RHHVF has Performed in-line its overall industry.
Next quarter’s earnings estimate for RHHVF is $10.83 with a range of $10.83 to $10.83. The previous quarter’s EPS was $13.85. RHHVF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year RHHVF has Performed in-line its overall industry.
RHHVF Sales Forecast
Next quarter’s sales forecast for RHHVF is $19.41B with a range of $18.70B to $20.16B. The previous quarter’s sales results were $38.69B. RHHVF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year RHHVF has Performed in-line its overall industry.
Next quarter’s sales forecast for RHHVF is $19.41B with a range of $18.70B to $20.16B. The previous quarter’s sales results were $38.69B. RHHVF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year RHHVF has Performed in-line its overall industry.
RHHVF Stock Forecast FAQ
What is RHHVF’s average 12-month price target, according to analysts?
Based on analyst ratings, Roche Holding AG’s 12-month average price target is 411.68.
What is RHHVF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for RHHVF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RHHVF a Buy, Sell or Hold?
Roche Holding AG has a consensus rating of Moderate Buy which is based on 5 buy ratings, 4 hold ratings and 2 sell ratings.
What is Roche Holding AG’s price target?
The average price target for Roche Holding AG is 411.68. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $500.42 ,the lowest forecast is $287.74. The average price target represents -6.26% Decrease from the current price of $439.16.
What do analysts say about Roche Holding AG?
Roche Holding AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of RHHVF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.